Senate Panel Targets 'Clever' Pharma Pricing

The Senate Judiciary Committee on Tuesday railed against drugmakers and pharmacy benefit managers for allegedly causing the high cost of prescription drugs, arguing that "Big Pharma" has used anticompetitive tactics through...

Already a subscriber? Click here to view full article